Development and validation of the Japanese version of the Public Attitudes Toward Epilepsy (PATE-J) Scale.

Autor: Hatakeda J; Department of Psychiatry, Higashi Matsuyama Hospital Medical Corporation Ryokukokai Saitama Japan.; Department of Psychiatry, Saitama Medical Center Saitama Medical University Saitama Japan., Shimazaki H; Department of Psychiatry, Saitama Medical Center Saitama Medical University Saitama Japan.; Department of Psychiatry Public Interest Foundation of Nishi Kumagaya Hospital Saitama Japan., Kuramochi I; Department of Psychiatry, Saitama Medical Center Saitama Medical University Saitama Japan., Iwayama T; Department of Psychiatry, Saitama Medical Center Saitama Medical University Saitama Japan.; Department of Psychology Showa Women's University Tokyo Japan., Kobayashi S; Department of Psychiatry, Saitama Medical Center Saitama Medical University Saitama Japan., Matsuki H; Department of Psychiatry, Saitama Medical Center Saitama Medical University Saitama Japan.; Medical Correction Center in East Japan Tokyo Japan., Yoshimasu H; Department of Psychiatry, Saitama Medical Center Saitama Medical University Saitama Japan., Lim KS; Department of Medicine, Division of Neurology, Faculty of Medicine University of Malaya Kuala Lumpur Malaysia.
Jazyk: angličtina
Zdroj: PCN reports : psychiatry and clinical neurosciences [PCN Rep] 2024 Dec 20; Vol. 3 (4), pp. e70045. Date of Electronic Publication: 2024 Dec 20 (Print Publication: 2024).
DOI: 10.1002/pcn5.70045
Abstrakt: Aim: This study aimed to develop and validate a Japanese version of the Public Attitudes Toward Epilepsy (PATE-J) Scale to measure attitudes towards epilepsy among the general Japanese population.
Methods: The study employed a cross-sectional design using an online survey of 537 participants from the general public in Japan, with follow-up surveys at 2 weeks and 3 months. The PATE Scale was translated following standard guidelines and validated by conducting confirmatory factor analysis (CFA) on the complete data set to assess the original two-factor structure of the PATE Scale. Internal consistency assessment, and convergent validity testing with the Modified Epilepsy Stigma Scale (M-ESS), Perceived Devaluation Discrimination Scale (PDDS), and Epilepsy Knowledge Scale (EKS) were carried out.
Results: CFA confirmed the two-factor structure of the PATE-J, comprising "Personal Domain" and "General Domain." The model showed acceptable fit indices ( χ ²(76) = 607.974, comparative fit index = 0.849, Tucker-Lewis index = 0.820, root-mean-square error of approximation = 0.114, standardized root-mean-square residual = 0.078) and high reliability (Cronbach's α  = 0.87 for Personal Domain and 0.75 for General Domain). Strong correlations with the M-ESS ( r  = 0.713, p  < 0.001), and weaker correlations with the PDDS, along with a negative correlation with the EKS ( r  = -0.306, p  < 0.001), highlighted the PATE-J's distinctiveness. No significant associations were found between demographic factors and PATE-J scores.
Conclusion: The PATE-J demonstrates strong psychometric properties and cultural relevance for measuring public attitudes toward epilepsy in Japan. Its validated two-factor structure supports cross-cultural comparisons and provides a reliable tool for assessing public attitudes, informing interventions, and guiding education campaigns.
Competing Interests: The authors declare no conflicts of interest.
(© 2024 The Author(s). Psychiatry and Clinical Neurosciences Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.)
Databáze: MEDLINE
Externí odkaz: